The discovery of Antibiotics

With few medicates available to enshroud such MDR bacteria and those that argon available being actually expensive, health professionals have been encouraged to ebb the hold of antibiotics unless this has not occurred. Despite some hospitals routinely changing which antibiotics they use and others prescribing alternative drugs, " topnotch-bugs" continue to emerge. As Ainsworth (2001) argues, "Although there was a 45-fold decrease in the use of sulphonamide antibiotics between 1991 and 1999, there was no simplification in the level of resistance in bacteria" (1).

using drugs to combat insects and pathogens in livestock has also increased the fast mutation of "super-bugs." Antibiotics, according to Weisberg (2003) are "fed unnecessarily to rosy-cheeked livestock, poultry and fish to promote slightly faster harvesting and to compensate for unsanitary conditions" (25). Human beings become susceptible because some(prenominal) antibiotics used on livestock are used on humans, making them ineffective against already resistant endeavours of bacteria. Because of the enormous be of developing antibiotics that will attack "super-bugs" effectively and because of the lower essence of such drugs needed by patients, many argue that pharmaceutic companies are not even developing new drugs to center on on "super-bugs." As Nelson (2003) contends, "Just as super bugs are becoming a greater holy terror, many pharmaceutical companies are curtailing their antibacterial research and development programs, and, in some case, displace out

The health partnership and researchers are in a race with such "super-bugs", forwards their numbers become a massive public health concern. During the anthrax attacks the shortage of antibiotics was highlighted. During major bacterial outbreaks, the health conjunction must rely on expensive antibiotics like Vancomycin, Methicillin, and Zyvox.

The resistance of "super-bugs" to more inexpensive antibiotics costs the United States between $30 billion and %50 billion to combat them on an yearbook basis, according to biologist Steve Palumbi (Stenger 2001). Cost of treating just one transmittal is much higher because of the resistant bacteria. Many argue that the U.S. health, research, and political science approach to fighting resistant bacteria is part of the problem. or else of a pro-active approach, Stenger (2001) maintains, "The present approach to combating super mutants is all demur and no offense: Wait for a new strain to emerge and then devise a new drug or pesticide to fight it" (1).

Will silver save us from the super-bugs? (May/Jun 1995). The Wholistic News Magazine, 42(18), 18-19.

Nelson, R. (Nov 22, 2003). Antibiotic development pipeline runs dry. Lancet, 362(9397), 1726-1727.

Weisberg, K. (Jan 15, 2003). Fight super bugs. FoodService Director, 16(1), 25-26.

The advent of "super-bugs" poses a major public health threat to the U.S. and countries around the world. Some hospitals switch antib
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!